In this year’s Invitational Lecture hosted by the Society for the Humanities, Hu Pegues will examine the story of Tillie Paul, a Tlingit woman in Alaska.
Cornell’s participation in the U.S. Commerce Department initiative will help advance development and deployment of safe and trustworthy artificial intelligence technology.
Students from the Brooks School’s State Policy Advocacy Clinic have teamed up with lawmakers and a community-based nonprofit representing formerly incarcerated mothers to introduce new legislation that would protect the rights of pre- and postnatal women in prisons and jails across New York.
Kersten, Ph.D. ’97, an experienced molecular nutrition researcher and academic leader, comes to Cornell from Wageningen University in the Netherlands, where he was most recently professor and chair of the Division of Human Nutrition and Health.
A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.
An interdisciplinary team of Cornell researchers has identified an innovative way to harness the antioxidant and antibacterial properties of the botanical compound lawsone to make nanofiber-coated cotton bandages that fight infection and help wounds heal more quickly.
While New York’s farmers face more extreme weather events, they are learning to adapt, says a new statewide climate impacts assessment, led and written by two Cornell researchers.
Cornell Tech and the SC Johnson College of Business have partnered to launch Generative AI for Business Transformation, a certificate program to help leaders harness the power of AI.
Outside of the token skate park, the diverse needs of New York state teens are often ignored when planners design public spaces. A new collaboration between a College of Human Ecology professor and Cornell Cooperative Extension seeks to put an end to that.
Alessio Accardi, professor of physiology and biophysics in anesthesiology at Weill Cornell Medicine, has been awarded a five-year, $2.7 million grant for fundamental research on cell membrane proteins that have critical roles in biology and are involved in numerous human diseases.
